Edward Smith
Directeur/Membre du Conseil chez SCORPIUS HOLDINGS, INC.
Fortune : 23 $ au 30/04/2024
Profil
Edward Byron Smith is the founder of Brightline Capital Management LLC, which was founded in 2005.
He held the title of Managing Member from 2005 to 2014.
Mr. Smith's current job(s) include Executive Chairman at Population Bio, Inc., Director at Elusys Therapeutics, Inc., Independent Director at Scorpius Holdings, Inc., Director at Pelican Therapeutics, Inc., Managing Member at Brightline Ventures I B LLC, Managing Member at Brightline Ventures I C LLC, Managing Member at Aristar Capital Management LLC, and Managing Member at Brightline Ventures I LLC.
Mr. Smith's former job(s) include Director at Agritech Worldwide, Inc. from 2009 to 2017, Analyst at P&S Capital Partners LLC in 2004, Analyst at Credit Suisse First Boston LLC in 1997, and Associate at GTCR LLC from 1999 to 2001.
Mr. Smith's education history includes an MBA from Harvard Business School in 2003 and an undergraduate degree from Harvard College in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCORPIUS HOLDINGS, INC.
0,00% | 26/04/2024 | 143 ( 0,00% ) | 23 $ | 30/04/2024 |
Postes actifs de Edward Smith
| Sociétés | Poste | Début |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/11/2010 |
| Brightline Ventures I LLC | Corporate Officer/Principal | - |
| Brightline Ventures I B LLC | Corporate Officer/Principal | - |
| Brightline Ventures I C LLC | Corporate Officer/Principal | - |
Aristar Capital Management LLC
 Aristar Capital Management LLC Investment ManagersFinance Aristar Capital Management LLC (Aristar Capital Mgmt) is a Venture Capital firm founded in 2009. The firm is headquartered in New York. | Directeur Général | 01/01/2015 |
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Directeur/Membre du Conseil | - |
Population Bio, Inc.
 Population Bio, Inc. Medical SpecialtiesHealth Technology Population Bio, Inc. is a CNV company to develop therapies and diagnostics. The company was founded by Jim Chinitz, Eli Hatchwell and Peggy S. Eis in 2006 and is headquartered in Melville, NY. | Président | - |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Directeur/Membre du Conseil | 01/11/2010 |
Anciens postes connus de Edward Smith
| Sociétés | Poste | Fin |
|---|---|---|
| AGRITECH WORLDWIDE, INC. | Directeur Général | 14/07/2017 |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Edward Smith
| Harvard College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Brightline Capital Management LLC
 Brightline Capital Management LLC Investment ManagersFinance Brightline Capital Management LLC (Brightline) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Miami, Florida. The firm was founded by Naval (Nick) Khera in 2005. Brightline serves as manager to limited partnerships formed in the US as privately-offered investment funds. | Finance |
Credit Suisse First Boston LLC
 Credit Suisse First Boston LLC Investment Banks/BrokersFinance Credit Suisse First Boston LLC provides global investment banking services in the United States. It provides private banking and financial advisory services and banking products. Its businesses include securities underwriting, sales & trading, investment banking, private equity, alternative assets, financial advisory services, investment research and asset management. It is headquartered in New York, NY. | Finance |
GTCR LLC
 GTCR LLC Investment ManagersFinance GTCR LLC (GTCR) is a private equity firm founded in 1980 by Charlie Thomas. The firm is headquartered in Chicago, Illinois. | Finance |
P&S Capital Partners LLC
 P&S Capital Partners LLC Investment ManagersFinance P&S Capital Partners LLC is a hedge fund manager located in New York City. The firm is also known as Gracie Capital. They manage the Gracie Capital International Ltd., the Gracie Capital LP and the Gracie Capital II LP | Finance |
Agritech Worldwide, Inc.
 Agritech Worldwide, Inc. Food: Major DiversifiedConsumer Non-Durables Agritech Worldwide, Inc. is an agricultural technology company, which engages in the sale of a line of all-natural products. The firm develops new commodities and processes that transform agricultural by products into multi functional ingredients used in food manufacturing and other industries. Its products include Z Trim and Oat Z Trim. The company was founded on May 5, 1994 and is headquartered in New York, NY. | Consumer Non-Durables |
| Brightline Ventures I LLC | |
| Brightline Ventures I B LLC | |
| Brightline Ventures I C LLC | |
Aristar Capital Management LLC
Aristar Capital Management LLC Investment ManagersFinance Aristar Capital Management LLC (Aristar Capital Mgmt) is a Venture Capital firm founded in 2009. The firm is headquartered in New York. | Finance |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
Population Bio, Inc.
Population Bio, Inc. Medical SpecialtiesHealth Technology Population Bio, Inc. is a CNV company to develop therapies and diagnostics. The company was founded by Jim Chinitz, Eli Hatchwell and Peggy S. Eis in 2006 and is headquartered in Melville, NY. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
